JP2017534259A5 - - Google Patents

Download PDF

Info

Publication number
JP2017534259A5
JP2017534259A5 JP2017514687A JP2017514687A JP2017534259A5 JP 2017534259 A5 JP2017534259 A5 JP 2017534259A5 JP 2017514687 A JP2017514687 A JP 2017514687A JP 2017514687 A JP2017514687 A JP 2017514687A JP 2017534259 A5 JP2017534259 A5 JP 2017534259A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
antibody
met
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017514687A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017534259A (ja
JP6927875B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2015/002110 external-priority patent/WO2016042412A1/en
Publication of JP2017534259A publication Critical patent/JP2017534259A/ja
Publication of JP2017534259A5 publication Critical patent/JP2017534259A5/ja
Application granted granted Critical
Publication of JP6927875B2 publication Critical patent/JP6927875B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017514687A 2014-09-16 2015-09-15 抗met抗体および組成物 Active JP6927875B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462051190P 2014-09-16 2014-09-16
US62/051,190 2014-09-16
PCT/IB2015/002110 WO2016042412A1 (en) 2014-09-16 2015-09-15 Anti-met antibodies and compositions

Publications (3)

Publication Number Publication Date
JP2017534259A JP2017534259A (ja) 2017-11-24
JP2017534259A5 true JP2017534259A5 (cg-RX-API-DMAC7.html) 2018-10-18
JP6927875B2 JP6927875B2 (ja) 2021-09-01

Family

ID=54780359

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017514687A Active JP6927875B2 (ja) 2014-09-16 2015-09-15 抗met抗体および組成物

Country Status (11)

Country Link
US (1) US10450376B2 (cg-RX-API-DMAC7.html)
EP (1) EP3194444B1 (cg-RX-API-DMAC7.html)
JP (1) JP6927875B2 (cg-RX-API-DMAC7.html)
KR (1) KR102200274B1 (cg-RX-API-DMAC7.html)
CN (1) CN107001471B (cg-RX-API-DMAC7.html)
AU (1) AU2015316522B2 (cg-RX-API-DMAC7.html)
CA (1) CA2961323C (cg-RX-API-DMAC7.html)
ES (1) ES2748295T3 (cg-RX-API-DMAC7.html)
IL (1) IL250902B (cg-RX-API-DMAC7.html)
MX (1) MX378108B (cg-RX-API-DMAC7.html)
WO (1) WO2016042412A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2864150T3 (es) 2016-05-17 2021-10-13 Abbvie Biotherapeutics Inc Conjugados de fármacos con anticuerpos anti-cMet y métodos para su uso
CA3036643C (en) 2016-09-29 2021-10-26 Mitsubishi Tanabe Pharma Corporation Cmet monoclonal binding agents, drug conjugates thereof and uses thereof
TWI782930B (zh) 2016-11-16 2022-11-11 美商再生元醫藥公司 抗met抗體,結合met之雙特異性抗原結合分子及其使用方法
KR20200012937A (ko) 2017-06-06 2020-02-05 지앙수 헨그루이 메디슨 컴퍼니 리미티드 c-Met 항체 약물 접합체를 포함하는 약학 조성물 및 그의 용도
SG11202009308WA (en) * 2018-03-28 2020-10-29 Mitsubishi Tanabe Pharma Corp DRUG CONJUGATES OF cMET MONOCLONAL BINDING AGENTS, AND USES THEREOF
KR102221755B1 (ko) * 2018-05-02 2021-03-02 (주)에임드바이오 c-Met에 특이적으로 결합하는 항체 및 그의 용도
KR102433184B1 (ko) * 2018-12-07 2022-08-17 서울대학교 산학협력단 항 c-Met 아고니스트 항체 및 이의 용도
AU2020308053A1 (en) * 2019-06-26 2022-01-20 Glaxosmithkline Intellectual Property Development Limited IL1RAP binding proteins
US11896682B2 (en) 2019-09-16 2024-02-13 Regeneron Pharmaceuticals, Inc. Radiolabeled MET binding proteins for immuno-PET imaging and methods of use thereof
WO2021058735A1 (en) 2019-09-26 2021-04-01 Symphogen A/S Cancer treatment with anti-met antibody compositions
WO2022204332A1 (en) * 2021-03-24 2022-09-29 Combangio, Inc. Compositions comprising c-met agonist antibodies and methods for use in ocular treatment
AU2022254291A1 (en) 2021-04-08 2023-10-12 Byondis B.V. Anti-c-met antibodies and antibody-drug conjugates
EP4472997A2 (en) * 2022-02-02 2024-12-11 The Broad Institute, Inc. Targeting moieties promoting transduction of central nervous system cells and tissues and methods of use
JP2025517429A (ja) 2022-05-20 2025-06-05 ノバルティス アーゲー Met bcl-xl阻害剤抗体-薬物コンジュゲートおよびその使用の方法
TW202500584A (zh) 2023-05-19 2025-01-01 法商施維雅藥廠 抗met抗體、抗體-藥物結合物、組合物及其用途

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4634665A (en) 1980-02-25 1987-01-06 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US5179017A (en) 1980-02-25 1993-01-12 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4510245A (en) 1982-11-18 1985-04-09 Chiron Corporation Adenovirus promoter system
US4740461A (en) 1983-12-27 1988-04-26 Genetics Institute, Inc. Vectors and methods for transformation of eucaryotic cells
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
JP2532858B2 (ja) 1985-04-01 1996-09-11 セルテツク リミテツド 形質転換したミエロ―マ細胞系
US4968615A (en) 1985-12-18 1990-11-06 Ciba-Geigy Corporation Deoxyribonucleic acid segment from a virus
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
US4959455A (en) 1986-07-14 1990-09-25 Genetics Institute, Inc. Primate hematopoietic growth factors IL-3 and pharmaceutical compositions
US4912040A (en) 1986-11-14 1990-03-27 Genetics Institute, Inc. Eucaryotic expression system
US5750172A (en) 1987-06-23 1998-05-12 Pharming B.V. Transgenic non human mammal milk
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
GB8809129D0 (en) 1988-04-18 1988-05-18 Celltech Ltd Recombinant dna methods vectors and host cells
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5959177A (en) 1989-10-27 1999-09-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
US5633076A (en) 1989-12-01 1997-05-27 Pharming Bv Method of producing a transgenic bovine or transgenic bovine embryo
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
AU665190B2 (en) 1990-07-10 1995-12-21 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DK0564531T3 (da) 1990-12-03 1998-09-28 Genentech Inc Berigelsesfremgangsmåde for variantproteiner med ændrede bindingsegenskaber
DK1279731T3 (da) 1991-03-01 2007-09-24 Dyax Corp Fremgangsmåde til udvikling af bindende miniproteiner
DK1471142T3 (da) 1991-04-10 2009-03-09 Scripps Research Inst Heterodimere receptor-biblioteker under anvendelse af fagemider
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
ATE181571T1 (de) 1991-09-23 1999-07-15 Medical Res Council Methoden zur herstellung humanisierter antikörper
CA2144856A1 (en) 1992-09-18 1994-03-31 Donna L. Faletto A method of preventing tumor metastasis
ES2146648T3 (es) 1993-03-09 2000-08-16 Genzyme Corp Procedimiento de aislamiento de proteinas de la leche.
US5827690A (en) 1993-12-20 1998-10-27 Genzyme Transgenics Corporatiion Transgenic production of antibodies in milk
US5707624A (en) 1994-06-03 1998-01-13 The Regents Of The University Of Michigan Treatment of Kaposi's sarcoma by inhibition of scatter factor
US6046037A (en) 1994-12-30 2000-04-04 Hiatt; Andrew C. Method for producing immunoglobulins containing protection proteins in plants and their use
US5686292A (en) 1995-06-02 1997-11-11 Genentech, Inc. Hepatocyte growth factor receptor antagonist antibodies and uses thereof
US6214344B1 (en) 1995-06-02 2001-04-10 Genetech, Inc. Hepatocyte growth factor receptor antagonists and uses thereof
IL127558A0 (en) 1996-07-03 1999-10-28 Genentech Inc Hepatocyte growth factor receptor agonists and uses thereof
EP0983303B1 (en) 1997-05-21 2006-03-08 Biovation Limited Method for the production of non-immunogenic proteins
WO2000009560A2 (en) 1998-08-17 2000-02-24 Abgenix, Inc. Generation of modified molecules with increased serum half-lives
ATE352559T1 (de) 1998-12-08 2007-02-15 Biovation Ltd Verfahren zur verminderung der immunogenität von proteinen
US6517529B1 (en) 1999-11-24 2003-02-11 Radius International Limited Partnership Hemodialysis catheter
EA013225B1 (ru) 2003-01-07 2010-04-30 Симфоген А/С Способ получения линии клеток, продуцирующей рекомбинантный поликлональный белок, способ получения поликлонального белка, линия клеток, продуцирующая рекомбинантный поликлональный белок, библиотека векторов, популяция клеток
ITMI20031127A1 (it) 2003-06-05 2004-12-06 Uni Degli Studi Del Piemont E Orientale Am Anticorpi anti-hgf-r e loro uso
HN2004000285A (es) 2003-08-04 2006-04-27 Pfizer Prod Inc ANTICUERPOS DIRIGIDOS A c-MET
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
CN1997382A (zh) 2004-05-05 2007-07-11 梅里麦克制药股份有限公司 调节生物活性的双特异性结合剂
PT1773885E (pt) 2004-08-05 2010-07-21 Genentech Inc Antagonistas anti-cmet humanizados
US7615529B2 (en) 2005-03-25 2009-11-10 Genentech, Inc. Methods and compositions for modulating hyperstabilized c-met
US20090068179A1 (en) 2005-11-16 2009-03-12 Fariba Nayeri Methods for Inhibiting Carcinogenesis and/or Metastasis in an Individual with Endogenous C-Met Ligands and Inhibitors
BRPI0707480A8 (pt) 2006-02-06 2022-11-08 Vertical Bio Ag Usos de um anticorpo monoclonal, um fragmento e/ou anticorpo geneticamente engenheirado ou humanizado, de uma seqüência de nucleotídeos e de um vetor, produto, e, método para triar compostos
CA2646620C (en) 2006-03-20 2015-07-14 Seikagaku Corporation Therapeutic agent for rheumatoid arthritis
JP5536445B2 (ja) 2006-03-30 2014-07-02 ノバルティス アーゲー c−Metの抗体の組成物およびその使用方法
US8039598B2 (en) 2007-01-19 2011-10-18 Van Andel Research Institute Met fab and SCFV fragments
EP2152872B1 (en) 2007-05-25 2010-09-15 Symphogen A/S Method for manufacturing a recombinant polyclonal protein
EP2014681A1 (en) 2007-07-12 2009-01-14 Pierre Fabre Medicament Novel antibodies inhibiting c-met dimerization, and uses thereof
US7892770B2 (en) 2007-08-24 2011-02-22 Van Andel Research Institute Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embedded tissues and related methods
WO2009129814A1 (en) 2008-04-23 2009-10-29 Symphogen A/S Methods for manufacturing a polyclonal protein
WO2009142738A2 (en) * 2008-05-21 2009-11-26 Oncomed Pharmaceuticals, Inc. Compositions and methods for diagnosing and treating cancer
EP4083072A1 (en) * 2008-10-06 2022-11-02 Minerva Biotechnologies Corporation Muc1* antibodies
PA8849001A1 (es) * 2008-11-21 2010-06-28 Lilly Co Eli Anticuerpos de c-met
JP6055312B2 (ja) 2010-03-10 2017-01-11 ゲンマブ エー/エス C−metに対するモノクローナル抗体
MX347981B (es) 2010-11-01 2017-05-22 Symphogen As Composicion de anticuerpos pan-her.
US8637027B2 (en) 2010-11-03 2014-01-28 Argen-X B.V. Anti c-Met antibodies

Similar Documents

Publication Publication Date Title
JP2017534259A5 (cg-RX-API-DMAC7.html)
JP2014503189A5 (cg-RX-API-DMAC7.html)
ES2662519T3 (es) Anticuerpos neutralizantes contra el virus de la gripe A y usos de estos
RU2504553C2 (ru) Антитела к her
FI3515487T3 (fi) Bispesifisiä anti-MUC16-CD3-vasta-aineita ja anti-MUC16-lääkekonjugaatteja
JP2020503001A5 (cg-RX-API-DMAC7.html)
RU2014103784A (ru) Антитело, блокирующее agr2, и его применение
RU2451689C2 (ru) Новые антипролиферативные антитела
JP2015517300A5 (cg-RX-API-DMAC7.html)
RU2012143793A (ru) Биспецифические двухвалентные антитела анти-vegf/анти-ang-2
JP2013520984A5 (cg-RX-API-DMAC7.html)
RU2018114904A (ru) Антитело против garp
JP2017532005A5 (cg-RX-API-DMAC7.html)
FI3137504T3 (fi) Fcrn:ään sitoutuva vasta-aine autoimmuunisairauksien hoitamista varten
JP2011527902A5 (cg-RX-API-DMAC7.html)
RU2013104830A (ru) Лечение рака при помощи направленных на мишень антител in vivo
RU2017107773A (ru) Антитела, специфичные к ммр9
RU2012131411A (ru) АНТИТЕЛА ПРОТИВ Bv8 И ИХ ПРИМЕНЕНИЕ
RU2016107814A (ru) Новое антитело к tslp-рецептору человека
US12252539B2 (en) Anti-FLT3 antibodies and compositions
JP2010509931A5 (cg-RX-API-DMAC7.html)
JP2015530989A5 (cg-RX-API-DMAC7.html)
JP2016520595A5 (cg-RX-API-DMAC7.html)
JP2014532706A5 (cg-RX-API-DMAC7.html)
JP2018508218A5 (cg-RX-API-DMAC7.html)